The National Drug Policy (synonyms also used; National Medicine, or; National Pharmaceutical policy for Timor Leste) deals with the development, provision and use of medicines within both the public and the private sector. The overarching goal is to secure safety and protect the individual patient and the public. The National Drugs and Medicines pharmaceuticals Policy aims to contribute to improved health and wellbeing of all people in Timor Leste.
This National Medicine Policy document aims for uninterrupted supply of safe, effective and good quality Essential Medicines, and promoting the rational and safe use of medicines both in public and private sectors throughout the country. For the National Medicine Policy to have impact, it must be owned by all stake holders and implemented through updated legislation and regulations, through a National Drug Administration as central Authority in line with WHO recommendations.
The National Drug Policy embraces all aspects of supply, quality, use and management of pharmaceuticals/medicines/drugs. The Policy addresses all drugs, both branded and generic, as well as biological products derived from living sources such as blood, blood products and vaccines as well as medicines of chemical composition, and products which are classified as so called traditional medicines or traditional health products.
A Drug, a Pharmaceutical or Medicine/Medicinal product is defined by its intended use, if it is intended for diagnostic, preventive, curative or palliative care for human use. Also products used for diagnostic, preventive of curative use in animals are classified as medicines.